Document Detail


Insulin-like growth factor axis (insulin-like growth factor-I/insulin-like growth factor-binding protein-3) as a prognostic predictor of heart failure: association with adiponectin.
MedLine Citation:
PMID:  20851819     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: Insulin-like growth factor (IGF)-I is a regulator of glucose/fatty acid metabolism and may be involved in the pathophysiology of cardiovascular disease, but it remains unclear whether endogenous IGF-I is associated with the prognosis of heart failure (HF). We investigated whether the IGF axis, the ratio of IGF-I to IGF-binding protein-3 (IGFBP-3), was a predictor of clinical outcomes in HF. The association of IGF axis with serum adiponectin level, a prognostic marker of HF as well as a regulator of glucose/fatty acid metabolism, was also analysed.
METHODS AND RESULTS: We measured serum IGF-I and IGFBP-3 in 142 HF patients with left ventricular systolic dysfunction and 63 control subjects. Patients with HF underwent clinical assessment and measurement of adiponectin and B-type natriuretic peptide (BNP). Compared with controls, HF patients showed significantly decreased serum IGF axis values [median (inter-quartile ranges), 0.114 (0.063-0.150) vs. 0.099 (0.052-0.158), P = 0.042]. In HF patients, the log-transformed IGF axis values were inversely correlated with the log-transformed serum adiponectin levels (r = -0.35, P < 0.0001) and plasma BNP levels (r = -0.25, P = 0.0028). The IGF axis was lower in patients with New York Heart Association (NYHA) functional class III/IV than those with class I/II [0.071 (0.044-0.145) vs. 0.107 (0.068-0.161), P = 0.022]. Furthermore, a decrease in IGF axis was associated with increased rates of all-cause mortality (P = 0.013), cardiac death (P = 0.035), and a composite of cardiac death and re-hospitalization (P = 0.0085).
CONCLUSION: Insulin-like growth factor axis is a significant predictor of clinical outcomes in HF and is significantly associated with serum adiponectin levels.
Authors:
Shin Watanabe; Toshihiro Tamura; Koh Ono; Hisanori Horiuchi; Takeshi Kimura; Toru Kita; Yutaka Furukawa
Related Documents :
3150929 - Separating output factor into collimator factor and phantom scatter factor for megavolt...
2167699 - Canine tracheal epithelial cells express the type 1 insulin-like growth factor receptor...
7532599 - Reduced insulin-like growth factor-i mrna content in liver, adrenal glands and spinal c...
15336229 - Free insulin-like growth factors -- measurements and relationships to growth hormone se...
8483809 - Preparation of n epsilon b28-monoazidobenzoyl insulin-like growth factor i and photoaff...
3604799 - Prospective study of restriction of activity in old people after falls.
7508209 - Metabolic and neurochemical profiles in insulin-treated diabetic rats.
17188609 - Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intr...
9678539 - Prolonged elimination of tolbutamide in a premature newborn with hyperinsulinaemic hypo...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-09-17
Journal Detail:
Title:  European journal of heart failure     Volume:  12     ISSN:  1879-0844     ISO Abbreviation:  Eur. J. Heart Fail.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-22     Completed Date:  2011-03-14     Revised Date:  2011-06-08    
Medline Journal Info:
Nlm Unique ID:  100887595     Medline TA:  Eur J Heart Fail     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1214-22     Citation Subset:  IM    
Affiliation:
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adiponectin / physiology*
Aged
Aged, 80 and over
Female
Heart Failure / blood*,  mortality*,  physiopathology
Humans
Insulin-Like Growth Factor Binding Protein 3 / analysis,  physiology*
Insulin-Like Growth Factor I / analysis,  physiology*
Male
Middle Aged
Multivariate Analysis
Natriuretic Peptide, Brain / blood
Prognosis
Proportional Hazards Models
Chemical
Reg. No./Substance:
0/Adiponectin; 0/Insulin-Like Growth Factor Binding Protein 3; 114471-18-0/Natriuretic Peptide, Brain; 67763-96-6/Insulin-Like Growth Factor I
Comments/Corrections
Comment In:
Eur J Heart Fail. 2010 Nov;12(11):1154-5   [PMID:  20923855 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Left ventricular systolic and diastolic function improve after acute myocardial infarction treated w...
Next Document:  Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensit...